glp 1 by mouth GLP-1 Receptor Agonists in Periodontology: Mechanisms, Clinical Evidence, and Implications for Care Dry Mouth from GLP-1 Injections

Walsh NP, Gleeson M, Shephard RJ, et al

The study, Medicare Part D Coverage and Costs for Glucagon-Like Peptide-1 Receptor Agonists, was published on September 25, 2025 in the JAMA

These advancements are supported by ongoing research and clinical trials, offering new ways to improve maternal health and long-term recovery

30 mL multi-dose plastic vial

SUPPORTING A BALANCED DIET: Maintaining a balanced diet can be challenging, especially when trying to reduce caloric intake

The most frequently reported side effects include gastrointestinal symptoms such as nausea, diarrhoea, vomiting, constipation, and abdominal pain , which affect a significant proportion of patients, particularly during dose escalation